Abstract
Annals of NeurologyVolume 91, Issue 2 p. 303-303 CorrigendumFree Access Corrigendum: Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency This article corrects the following: Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency Carlos Lopez-Gomez PhD, Maria J. Sanchez-Quintero PhD, Eung Jeon Lee BS, Giulio Kleiner PhD, Saba Tadesse MS, Jun Xie PhD, Hasan Orhan Akman PhD, Guangping Gao PhD, Michio Hirano MD, Volume 90Issue 4Annals of Neurology pages: 640-652 First Published online: August 13, 2021 First published: 06 January 2022 https://doi.org/10.1002/ana.26295AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat In the article “Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency,”1 on the title page, one of the co-author's names was misspelled. The misspelled name Gulio Kleiner should be changed to Giulio Kleiner. Reference 1Lopez-Gomez C, Sanchez-Quintero MJ, Lee EJ, et al. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency. Ann Neurol 2021; 90: 640– 652. Volume91, Issue2February 2022Pages 303-303 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
